• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在三室塑料袋中制备的全营养混合液中的脂质球大小。

Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags.

作者信息

Driscoll David F, Thoma Andrea, Franke Rolf, Klütsch Karsten, Nehne Jörg, Bistrian Bruce R

机构信息

Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.

出版信息

Am J Health Syst Pharm. 2009 Apr 1;66(7):649-56. doi: 10.2146/ajhp080164.

DOI:10.2146/ajhp080164
PMID:19299372
Abstract

PURPOSE

The stability of injectable lipid emulsions in three-chamber plastic (3CP) bags, applying the globule-size limits established by United States Pharmacopeia ( USP ) chapter 729, was studied.

METHODS

A total of five premixed total nutrient admixture (TNA) products packaged in 3CP bags from two different lipid manufacturers containing either 20% soybean oil or a mixture of soybean oil and medium-chain-triglyceride oil as injectable lipid emulsions were tested. Two low-osmolarity 3CP bags and three high-osmolarity 3CP bags were studied. All products were tested with the addition of trace elements and multivitamins. All additive conditions (with and without electrolytes) were tested in triplicate at time 0 (immediately after mixing) and at 6, 24, 30, and 48 hours after mixing; the bags were stored at 24-26 degrees C. All additives were equally distributed in each bag for comparative testing, applying both globule sizing methods outlined in USP chapter 729.

RESULTS

Of the bags tested, all bags from one manufacturer were coarse emulsions, showing signs of significant growth in the large-diameter tail when mixed as a TNA formulation and failing the limits set by method II of USP chapter 729 from the outset and throughout the study, while the bags from the other manufacturer were fine emulsions and met these limits. Of the bags that failed, significant instability was noted in one series containing additional electrolytes.

CONCLUSION

Injectable lipid emulsions provided in 3CP bags that did not meet the globule-size limits of USP chapter 729 produced coarser TNA formulations than emulsions that met the USP limits.

摘要

目的

研究了按照美国药典(USP)第729章规定的液滴尺寸限制,注射用脂质乳剂在三室塑料(3CP)袋中的稳定性。

方法

测试了总共五种预混全营养混合液(TNA)产品,这些产品包装在来自两家不同脂质制造商的3CP袋中,含有20%的大豆油或大豆油与中链甘油三酯油的混合物作为注射用脂质乳剂。研究了两个低渗透压3CP袋和三个高渗透压3CP袋。所有产品都添加微量元素和多种维生素进行测试。所有添加条件(有电解质和无电解质)在混合后0小时(立即混合后)以及混合后6、24、30和48小时进行一式三份测试;袋子在24 - 26摄氏度下储存。所有添加剂在每个袋子中均匀分布以进行对比测试,采用USP第729章概述的两种液滴尺寸测量方法。

结果

在测试的袋子中,来自一个制造商的所有袋子都是粗乳液型,当作为TNA制剂混合时,在大直径尾部显示出显著增长的迹象,从一开始到整个研究过程都未达到USP第729章方法II设定的限值,而来自另一个制造商的袋子是细乳液型且符合这些限值。在未达标的袋子中,在一个含有额外电解质的系列中观察到显著的不稳定性。

结论

3CP袋中提供的不符合USP第729章液滴尺寸限制的注射用脂质乳剂,与符合USP限值的乳剂相比,会产生更粗的TNA制剂。

相似文献

1
Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags.在三室塑料袋中制备的全营养混合液中的脂质球大小。
Am J Health Syst Pharm. 2009 Apr 1;66(7):649-56. doi: 10.2146/ajhp080164.
2
Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging.玻璃包装与塑料包装的全营养混合液与脂肪乳注射液的稳定性
Am J Health Syst Pharm. 2007 Feb 15;64(4):396-403. doi: 10.2146/ajhp060062.
3
Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements.注射用20%脂质乳剂中的液滴大小分布:符合美国药典要求。
Am J Health Syst Pharm. 2007 Oct 1;64(19):2032-6. doi: 10.2146/ajhp070097.
4
Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging.通过模拟注射器输注研究20%脂质注射乳剂的物理稳定性:玻璃与塑料产品包装的影响
JPEN J Parenter Enteral Nutr. 2007 Mar-Apr;31(2):148-53. doi: 10.1177/0148607107031002148.
5
The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion.塑料容器中静脉注射用脂肪乳剂的药典演变:从粗分散到细分散。
Int J Pharm. 2009 Feb 23;368(1-2):193-8. doi: 10.1016/j.ijpharm.2008.09.059. Epub 2008 Oct 19.
6
Comment to "The pharmacopeial evolution of Intralipid injectable emulsion in plastic containers: from a coarse to a fine emulsion".评论“塑料容器中注射用脂肪乳剂的药典演变:从粗乳到细乳”。
Int J Pharm. 2010 Jun 15;392(1-2):198-200. doi: 10.1016/j.ijpharm.2010.03.045. Epub 2010 Mar 27.
7
Container effects on the physicochemical properties of parenteral lipid emulsions.容器对肠外脂质乳剂物理化学性质的影响。
Nutrition. 2008 Nov-Dec;24(11-12):1182-8. doi: 10.1016/j.nut.2008.06.003. Epub 2008 Aug 15.
8
Droplet-size distribution and stability of lipid injectable emulsions.脂质注射乳剂的液滴大小分布与稳定性
Am J Health Syst Pharm. 2009 Jan 15;66(2):162-6. doi: 10.2146/ajhp080031.
9
Droplet-size distribution and stability of commercial injectable lipid emulsions containing fish oil.商业注射用含鱼油脂肪乳剂的液滴大小分布和稳定性。
Am J Health Syst Pharm. 2012 Aug 1;69(15):1332-5. doi: 10.2146/ajhp110520.
10
Lipid injectable emulsions: 2006.脂质注射乳剂:2006年。
Nutr Clin Pract. 2006 Aug;21(4):381-6. doi: 10.1177/0115426506021004381.

引用本文的文献

1
Optical Microscopy as a Tool for Assessing Parenteral Nutrition Solution Stability: A Proof of Concept.光学显微镜作为评估肠外营养溶液稳定性的工具:概念验证
Pharmaceuticals (Basel). 2024 Oct 5;17(10):1330. doi: 10.3390/ph17101330.
2
Physicochemical Stability of Hospital Parenteral Nutrition Solutions: Effect of Changes in Composition and Storage Protocol.医院胃肠外营养制剂的物理化学稳定性:成分变化及储存方案的影响
Pharmaceutics. 2024 Apr 23;16(5):572. doi: 10.3390/pharmaceutics16050572.
3
Evaluation of the Stability of Newborn Hospital Parenteral Nutrition Solutions.
新生儿医院肠外营养制剂稳定性评估
Pharmaceutics. 2024 Feb 23;16(3):316. doi: 10.3390/pharmaceutics16030316.
4
Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration.酮洛芬与用于中心和外周给药的肠外营养混合液的Y型接口相容性研究。
Pharmaceutics. 2022 Nov 23;14(12):2570. doi: 10.3390/pharmaceutics14122570.
5
Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures.伏立康唑在全合一肠外营养混合液中的理化稳定性及配伍性试验
Pharmaceutics. 2021 Sep 10;13(9):1447. doi: 10.3390/pharmaceutics13091447.
6
All-in-One Pediatric Parenteral Nutrition Admixtures with an Extended Shelf Life-Insight in Correlations between Composition and Physicochemical Parameters.具有延长保质期的一体化儿科肠外营养混合液——成分与物理化学参数之间的相关性洞察
Pharmaceutics. 2021 Jul 2;13(7):1017. doi: 10.3390/pharmaceutics13071017.
7
Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.全胃肠外营养与静脉用药 Y 型接口兼容性测试程序的开发与评估
Nutr J. 2016 Mar 22;15:29. doi: 10.1186/s12937-016-0149-x.
8
Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca2+ additive under clinical application circumstances.在临床应用情况下,高剂量 Ca2+添加剂存在时全合一肠外营养液混合物的动力学稳定性。
Nutr J. 2012 May 16;11:32. doi: 10.1186/1475-2891-11-32.